We are delighted to announce that the Calypso trial from Amolyt Pharma has arrived in the UK . For those with chronic hypoparathyroidism, the study will test a new investigational medication, called eneboparatide. Find out… [Read More]
UPDATE – 22nd Nov 2023 – recordings of the webinar are now available in English, French, Spanish and German on the European Society of Endocrinology website or on our You Tube channel. Watch talks and… [Read More]
We were invited to exhibit for the first time at the World Cancer for Thyroid Cancer in London on 16th & 17th June where we were represented by Deputy CEO Lucy Weigall and, for the… [Read More]
You are warmly invited to attend our first webinar on Primary Hyperparathyroidism to be held on Thursday July 6th 2023 at 8pm -9pm followed by an interactive Q&A. You will need to register before the… [Read More]
You are warmly invited to attend our first webinar entitled ‘Hypoparathyroidism: Information Update 2023’ to be held on June 8th at 8pm BST followed by an interactive Q&A. Here is the link to register… [Read More]
We are delighted to invite you to take part in this excellent survey looking at symptom management in people with hypoparathyroidism. It aims to compare symptoms in people who take calcium supplements and those who… [Read More]
We attended the ECE2023 in Istanbul virtually this year and were very pleased to see parathyroid conditions so well represented. We report the main sessions below. In the first Meet the Expert session Professor… [Read More]
This week Parathyroid UK attended the Society for Endocrinology’s Clinical update training programme for recently appointed consultants in diabetes and endocrinology. It provides an update on current clinical practice and offers delegates an unparalleled opportunity… [Read More]
On Friday 24th March we attended the Society of Endocrinology National Clinical Cases at the RSM in London. This is a training day for endocrinologists who have the chance to showcase their work in the… [Read More]
The NIFTy trial is now recruiting in several hospitals around the UK until 31/12/2023. It is open to people who are having total thyroid surgery, to remove the whole thyroid, or completion surgery to remove… [Read More]
